ADVERTISEMENT

ERS 2022 — Bronchodilators don’t improve symptoms in smokers without airflow obstruction

Drishti Agarwal   |   Conference Report   |   09 September 2022
ADVERTISEMENT

Takeaway

  • Inhaled bronchodilators do not improve respiratory symptoms in symptomatic, tobacco-exposed individuals with preserved spirometry, only those with lung damage enough to disrupt normal spirometry readings benefit from bronchodilator therapy.

A long-acting bronchodilator is the first choice for therapy in patients with chronic obstructive pulmonary disease (COPD). Spirometry shows evidence...

          

September Challenge

Ends in 7d 3h
left
right

Topic Challenges

left
right